Advanced search
Publication Cover
Cancer Investigation Volume 27, 2009 - Issue 1
Submit an article Journal homepage
100
Views
17
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES Clinical Translational Therapeutics

Metastatic Breast Cancer: Overall Survival Related to Successive Chemotherapies. What Do We Gain After the Third Line?

Olivier Tacca Bureau de Recherche Clinique, Centre Jean Perrin, Clermont-Ferrand Cédex 1, France; EA 4231, Clermont-Ferrand Cédex 1, France
,
Marianne LeHeurteur Bureau de Recherche Clinique, Centre Jean Perrin, Clermont-Ferrand Cédex 1, France
,
Xavier Durando Bureau de Recherche Clinique, Centre Jean Perrin, Clermont-Ferrand Cédex 1, France
,
Marie-Ange Mouret-Reynier Bureau de Recherche Clinique, Centre Jean Perrin, Clermont-Ferrand Cédex 1, France
,
Catherine Abrial Bureau de Recherche Clinique, Centre Jean Perrin, Clermont-Ferrand Cédex 1, France; EA 4231, Clermont-Ferrand Cédex 1, France
,
Emilie Thivat Bureau de Recherche Clinique, Centre Jean Perrin, Clermont-Ferrand Cédex 1, France; EA 4231, Clermont-Ferrand Cédex 1, France
,
Mathilde Bayet-Robert Bureau de Recherche Clinique, Centre Jean Perrin, Clermont-Ferrand Cédex 1, France; EA 4231, Clermont-Ferrand Cédex 1, France
,
Frederique Penault-Llorca Bureau de Recherche Clinique, Centre Jean Perrin, Clermont-Ferrand Cédex 1, France; EA 4231, Clermont-Ferrand Cédex 1, France; Université d'Auvergne, Clermont-Ferrand Cédex 1, France
&
Phillippe Chollet Bureau de Recherche Clinique, Centre Jean Perrin, Clermont-Ferrand Cédex 1, France; EA 4231, Clermont-Ferrand Cédex 1, France; Université d'Auvergne, Clermont-Ferrand Cédex 1, France; Centre d'Investigation Clinique, Clermont-Ferrand Cédex 1, France
 show all
Pages 81-85 | Published online: 11 Jun 2009

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Anouk K. M. Claessens, Frans L. G. Erdkamp, Marta Lopez-Yurda, Jeanette M. Bouma, Jeany M. Rademaker-Lakhai, Aafke H. Honkoop, Hiltje de Graaf, Vivianne C. G. Tjan-Heijnen & Monique E. M. M. Bos. (2020) Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancer. Acta Oncologica 59:6, pages 713-722.
Read now
E. Planchat, X. Durando, C. Abrial, E. Thivat, M. A. Mouret-Reynier, J. P. Ferrière, C. Pomel, F. Kwiatkowski, P. Chollet & J. M. Nabholtz. (2011) Prognostic Value of Initial Tumor Parameters After Metastatic Relapse. Cancer Investigation 29:9, pages 635-643.
Read now

Articles from other publishers (15)

Luc Cabel, Frédérique Berger, Paul Cottu, Delphine Loirat, Aurore Rampanou, Etienne Brain, Stacy Cyrille, Hugues Bourgeois, Nicolas Kiavue, Elise Deluche, Sylvain Ladoire, Mario Campone, Jean-Yves Pierga & Francois-Clement Bidard. (2021) Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial. British Journal of Cancer 124:7, pages 1207-1213.
Crossref
Anouk K.M. Claessens, Khava I.E. Ibragimova, Sandra M.E. Geurts, Monique E.M.M. Bos, Frans L.G. Erdkamp & Vivianne C.G. Tjan-Heijnen. (2020) The role of chemotherapy in treatment of advanced breast cancer: an overview for clinical practice. Critical Reviews in Oncology/Hematology 153, pages 102988.
Crossref
Luc Cabel, Matthieu Carton, Bianca Cheaib, Jean-Yves Pierga, Florence Dalenc, Audrey Mailliez, Christelle Levy, William Jacot, Marc Debled, Marianne Leheurteur, Isabelle Desmoulins, Claudia Lefeuvre, Anthony Gonçalves, Lionel Uwer, Jean-Marc Ferrero, Jean-Christophe Eymard, Thierry Petit, Marie-Ange Mouret-Reynier, Geneviève Perrocheau, Irwin Piot, David Pérol, Gaëtane Simon & Florence Lerebours. (2018) Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens. Breast Cancer Research and Treatment 173:2, pages 397-406.
Crossref
Russell Burcombe. (2017) Current treatment of HER 2+ metastatic breast cancer. British Journal of Nursing 26:Sup16a, pages S7-S14.
Crossref
Claire Ryan. (2017) Introduction. British Journal of Nursing 26:Sup16a, pages S4-S6.
Crossref
Claire Ryan, Russell Burcombe & Tracey Coleby. (2017) Foreword. British Journal of Nursing 26:Sup16a, pages S3-S3.
Crossref
Claire Ryan. (2017) Improving patient care: expert nursing and service development. British Journal of Nursing 26:Sup16a, pages S21-S25.
Crossref
Tracey Coleby. (2017) Defining what matters most to patients. British Journal of Nursing 26:Sup16a, pages S15-S20.
Crossref
Kirstine Skov Benthien, Mie Nordly, Katja Videbæk, Geana Paula Kurita, Hans von der Maase, Helle Timm, Mette Kildevæld Simonsen, Christoffer Johansen & Per Sjøgren. (2015) Classification of a palliative care population in a comprehensive cancer centre. Supportive Care in Cancer 24:4, pages 1865-1873.
Crossref
Thomas Filleron, Franck Bonnetain, Julien Mancini, Alejandra Martinez, Henri Roché & Florence Dalenc. (2015) Prospective construction and validation of a prognostic score to identify patients who benefit from third-line chemotherapy for metastatic breast cancer in terms of overall survival: The METAL3 Study. Contemporary Clinical Trials 40, pages 1-8.
Crossref
Raffaella Palumbo, Federico Sottotetti, Alberto Riccardi, Cristina Teragni, Emma Pozzi, Erica Quaquarini, Barbara Tagliaferri & Antonio Bernardo. (2013) Which patients with metastatic breast cancer benefit from subsequent lines of treatment? An update for clinicians. Therapeutic Advances in Medical Oncology 5:6, pages 334-350.
Crossref
Xinmin Zhao, Xiaofeng Xu, Qunling Zhang, Zhen Jia, Si Sun, Jian Zhang, Biyun Wang, Zhonghua Wang & Xichun Hu. (2011) Prognostic and predictive value of clinical and biochemical factors in breast cancer patients with bone metastases receiving "metronomic" zoledronic acid. BMC Cancer 11:1.
Crossref
E. Planchat, C. Abrial, E. Thivat, M.A. Mouret-Reynier, F. Kwiatkowski, C. Pomel, Q. Wang-Lopez, P. Chollet, J.M. Nabholtz & X. Durando. (2011) Late lines of treatment benefit survival in metastatic breast cancer in current practice?. The Breast 20:6, pages 574-578.
Crossref
Nam P. Nguyen, Fabio S. Almeida, Alex Chi, Ly M. Nguyen, Deirdre Cohen, Ulf Karlsson & Vincent Vinh-Hung. (2010) Molecular biology of breast cancer stem cells: Potential clinical applications. Cancer Treatment Reviews 36:6, pages 485-491.
Crossref
Elodie Vauléon, Habiba Mesbah, Brigitte Laguerre, Daniel Gédouin, Claudia Lefeuvre-Plesse, Jean Levêque, Odile Audrain & Pierre Kerbrat. (2009) Usefulness of chemotherapy beyond the second line for metastatic breast cancer: a therapeutic challenge. Cancer Chemotherapy and Pharmacology 66:1, pages 113-120.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.